Please login to the form below
Chiltern International lines up Dr Jim Esinhart as next CEO
He will replace Glenn Kerkhof from November 1, 2012
Chiltern International has selected Dr Jim Esinhart to be its next CEO with effect from November 1, 2012.
He will replace Glenn Kerkhof, who is stepping down as CEO of the London-based contract research organisation (CRO) after six years in the post.
Kerkhof will relocate to his native Australia to lead Chiltern's owner Czura Thornton in Asia Pacific, but will join Chiltern's board of directors.
Chiltern's new CEO Dr Esinhart has been with the company for six years and is currently senior executive vice president of global scientific services.
Kerkhof said: “I am delighted to have played my part in the development of Chiltern as a leading mid-tier CRO. Chiltern now employs more than 1,400 people in 34 countries, is financially very strong and is poised for substantial growth.
“I am also delighted to see the CEO position transition to a valued and trusted colleague in Jim Esinhart, who I know will bring a tremendous amount to the role. And I very much look forward to contributing to Chiltern's future as a member of the Board based in the Asia Pacific region.”
Featured jobs
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
AMICULUM Limited
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
